Cargando…
Bone marrow activation in response to metabolic syndrome and early atherosclerosis
AIMS: Experimental studies suggest that increased bone marrow (BM) activity is involved in the association between cardiovascular risk factors and inflammation in atherosclerosis. However, human data to support this association are sparse. The purpose was to study the association between cardiovascu...
Autores principales: | Devesa, Ana, Lobo-González, Manuel, Martínez-Milla, Juan, Oliva, Belén, García-Lunar, Inés, Mastrangelo, Annalaura, España, Samuel, Sanz, Javier, Mendiguren, José M, Bueno, Hector, Fuster, Jose J, Andrés, Vicente, Fernández-Ortiz, Antonio, Sancho, David, Fernández-Friera, Leticia, Sanchez-Gonzalez, Javier, Rossello, Xavier, Ibanez, Borja, Fuster, Valentin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113301/ https://www.ncbi.nlm.nih.gov/pubmed/35567559 http://dx.doi.org/10.1093/eurheartj/ehac102 |
Ejemplares similares
-
Association Between Body Size Phenotypes and Subclinical Atherosclerosis
por: Rossello, Xavier, et al.
Publicado: (2020) -
Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis
por: Devesa, Ana, et al.
Publicado: (2023) -
Triglycerides and Residual Atherosclerotic Risk
por: Raposeiras-Roubin, Sergio, et al.
Publicado: (2021) -
Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study
por: Sánchez-Cabo, Fátima, et al.
Publicado: (2023) -
Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis
por: Núñez, Estefanía, et al.
Publicado: (2022)